Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
3.740
-0.150 (-3.86%)
At close: Dec 5, 2025, 4:00 PM EST
3.810
+0.070 (1.87%)
After-hours: Dec 5, 2025, 6:01 PM EST
Zura Bio Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Zura Bio stock have an average target of 11.38, with a low estimate of 2.00 and a high estimate of 18. The average target predicts an increase of 204.28% from the current stock price of 3.74.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Zura Bio stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 4 |
| Buy | 4 | 4 | 5 | 4 | 4 | 3 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 10 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +167.38% | Nov 14, 2025 |
| Clear Street | Clear Street | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +381.28% | Nov 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +167.38% | Sep 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | -46.52% | Aug 19, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +327.81% | Aug 15, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.77
from -0.60
EPS Next Year
-0.79
from -0.77
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.78 | -0.74 | |
| Avg | -0.77 | -0.79 | |
| Low | -0.75 | -0.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.